Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$2.6B |
| 2 |
Abbott
ABT
|
+$1.29B |
| 3 |
Home Depot
HD
|
+$1.03B |
| 4 |
Devon Energy
DVN
|
+$888M |
| 5 |
PepsiCo
PEP
|
+$880M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.6B |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$1.5B |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$1.34B |
| 4 |
Texas Instruments
TXN
|
+$1.32B |
| 5 |
Coterra Energy
CTRA
|
+$789M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Financials | 10.61% |
| 3 | Healthcare | 10.33% |
| 4 | Miscellaneous | 9.93% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3201
RGC Resources
RGCO
$232M
| $586K | ﹤0.01% |
24,510
+3,210
| +15% | +$73.9K |
2023 Q2
12 quarters
|
|
3202
TON Strategy Co
TONX
$177M
| $586K | ﹤0.01% |
229,618
-41,179
| -15% | -$122K |
2025 Q3
3 quarters
|
|
3203
Perma-Pipe International
PPIH
$257M
| $585K | ﹤0.01% |
+21,484
| New | +$663K |
2026 Q2
0 quarters
|
|
3204
RF Industries
RFIL
$90.1M
| $582K | ﹤0.01% |
+27,443
| New | +$444K |
2026 Q2
0 quarters
|
|
|
MDV
3205
DELISTED
Modiv Industrial
MDV
| $581K | ﹤0.01% |
33,399
+4,367
| +15% | +$75K |
2025 Q2
4 quarters
|
|
3206
Taylor Devices
TAYD
$190M
| $577K | ﹤0.01% |
+9,837
| New | +$532K |
2026 Q2
0 quarters
|
|
3207
DELISTED
Emerald Holding
EEX
| $564K | ﹤0.01% |
111,932
-8,619
| -7% | -$41.9K |
2023 Q2
12 quarters
|
|
3208
American Resources Corp
AREC
$170M
| $564K | ﹤0.01% |
262,189
+216,189
| +470% | +$483K |
2026 Q1
1 quarter
|
|
3209
Crawford & Co Class A
CRD.A
$609M
| $560K | ﹤0.01% |
49,710
+3,514
| +8% | +$37.4K |
2016 Q3
39 quarters
|
|
3210
Eagle Financial Services Inc
EFSI
$246M
| $559K | ﹤0.01% |
13,488
+941
| +7% | +$36.9K |
2025 Q2
4 quarters
|
|
3211
Inhibikase Therapeutics
IKT
$275M
| $558K | ﹤0.01% |
275,041
+39,627
| +17% | +$70.9K |
2025 Q2
4 quarters
|
|
3212
Peoples Bancorp of North Carolina
PEBK
$233M
| $556K | ﹤0.01% |
12,896
+2,116
| +20% | +$87.8K |
2024 Q2
8 quarters
|
|
3213
InfuSystem Holdings
INFU
$270M
| $556K | ﹤0.01% |
57,584
+46,866
| +437% | +$444K |
2023 Q1
13 quarters
|
|
3214
Core Molding Technologies
CMT
$206M
| $554K | ﹤0.01% |
23,466
+3,302
| +16% | +$81.2K |
2023 Q2
12 quarters
|
|
3215
Meridian
MRBK
$222M
| $553K | ﹤0.01% |
27,600
+3,881
| +16% | +$73.6K |
2025 Q2
4 quarters
|
|
3216
Limoneira
LMNR
$218M
| $552K | ﹤0.01% |
42,021
-1,369
| -3% | -$17.6K |
2023 Q2
12 quarters
|
|
3217
Microvision
MVIS
$36.7M
| $549K | ﹤0.01% |
111,863
-29,784
| -21% | -$246K |
2019 Q1
29 quarters
|
|
3218
Codexis
CDXS
$154M
| $547K | ﹤0.01% |
242,211
| – | – |
2016 Q2
40 quarters
|
|
3219
Forrester Research
FORR
$217M
| $545K | ﹤0.01% |
64,854
-24,085
| -27% | -$157K |
2013 Q2
52 quarters
|
|
3220
Galectin Therapeutics
GALT
$397M
| $540K | ﹤0.01% |
116,424
+86,414
| +288% | +$224K |
2025 Q3
3 quarters
|
|
3221
Foghorn Therapeutics
FHTX
$119M
| $536K | ﹤0.01% |
109,781
+6,256
| +6% | +$27.8K |
2020 Q4
22 quarters
|
|
3222
KORU Medical Systems
KRMD
$137M
| $532K | ﹤0.01% |
126,710
+18,829
| +17% | +$77.1K |
2022 Q1
17 quarters
|
|
3223
Voyager Therapeutics
VYGR
$151M
| $530K | ﹤0.01% |
151,451
+26,338
| +21% | +$99.9K |
2022 Q1
17 quarters
|
|
3224
Starfighters Space Inc
FJET
$88M
| $530K | ﹤0.01% |
99,562
+74,562
| +298% | +$446K |
2026 Q1
1 quarter
|
|
3225
Acacia Research
ACTG
$422M
| $522K | ﹤0.01% |
112,016
+7,297
| +7% | +$35.1K |
2013 Q2
52 quarters
|
|
Similar funds
Charles Schwab's Q2 2026 Portfolio in Review
As of Q2 2026, Charles Schwab held 3,591 positions worth $751B, up 15% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab's Q2 2026 filing shows 136 new, 2,145 increased, 1,132 reduced and 153 closed positions. Its largest new stake was Honeywell Aerospace: 2,031,187 shares worth $449M. The largest sale was Qualcomm, an estimated $1.6B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2026 buy was Honeywell Aerospace: 2,031,187 shares worth $449M.
- Charles Schwab added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $2.6B increase.
- Charles Schwab's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $1.6B.
- Charles Schwab fully exited Coterra Energy in Q2 2026, selling an estimated $789M.
- Charles Schwab's ten largest holdings make up 22% of its $751B portfolio in Q2 2026.
- Charles Schwab opened 136 new positions and closed 153 in Q2 2026.
- Charles Schwab's portfolio value rose 15% quarter-over-quarter to $751B.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.